18:43:58 EDT Tue 21 May 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Titan Medical Inc (2)
Symbol TMD
Shares Issued 111,890,707
Close 2022-11-01 C$ 0.65
Market Cap C$ 72,728,960
Recent Sedar Documents

Titan Medical to release Q3 results Nov. 10

2022-11-02 12:31 ET - News Release

Mr. Cary Vance reports

TITAN MEDICAL TO ISSUE THIRD QUARTER 2022 FINANCIAL RESULTS ON NOVEMBER 10, 2022

Titan Medical Inc. plans to issue its third quarter 2022 financial results prior to market opening on Thursday, Nov. 10, 2022. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business developments in the period. Speakers will include Cary Vance, President and Chief Executive Officer, Stephen Lemieux, Chief Financial Officer and Kristen Galfetti, VP Investor Relations.

A link to the live audio webcast will be made available on the "Investor Relations" section of the company's website, www.titanmedicalinc.com. A webcast replay will be archived and accessible on the company's website shortly after conclusion of the live audio webcast.

About Titan Medical

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company headquartered in Toronto, Ontario and with operations in Chapel Hill, North Carolina, is focused on enhancing robotic assisted surgery (RAS) using innovative technology through a single access point. The Enos(TM) single-access RAS system is being developed with an ergonomic focus to provide a surgical experience that imitates real-life movements that surgeons demand. The Enos system includes multi-articulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. Titan intends to initially pursue gynaecological surgical indications with the Enos system.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.